Tag:
Royal Philips Electronics
Latest Headlines
Latest Headlines
RAND pushes remote care to ease health system demand
Like so many others who follow healthcare, researchers at RAND believe home-based technology, such as remote monitoring devices and telemedicine, have great potential to rein in healthcare costs and
Remote patient monitoring is only 'overhyped' if you're stuck in last century
Someone misses the point again. Remember my column last week , in which I took telephone-based telemedicine to task--and also chided the Los Angeles Times for referring to this approach as a "a good,
Boeing challenges GE, IBM, Philips over wireless spectrum for patient monitoring
The high hopes that some medical device makers have for wireless patient monitoring technologies may get grounded--if aerospace giant Boeing gets its way. As General Electric, IBM, Royal Philips
Study: Home telehealth, vitals monitoring cuts admissions for heart failure
A home-based interactive telehealth system with motivational support tools built in was able to reduce hospitalization rates by two-thirds, cut inpatient days by nearly three-fourths and
Phone companies chase profits, face medical heavyweights in m-health
We've reported plenty on how various telecommunications companies have been moving into mobile healthcare. Isn't it clear why? "All telcos face the same challenge: the commoditization of our core
Doctors and manufacturers aim to decrease CT radiation exposure, especially for kids
The high-powered imaging technology of CT scans allows doctors to see into crevices of the body that cannot be viewed as well by other methods. But the radiation exposure from the CT scans also can
GE, Siemens among top CT scan-makers to pledge tighter safety controls
The top five CT scan manufacturers are about to install more stringent safety controls after numerous reports of patients receiving potentially lethal doses of radiation. In the most recent case,
Novartis embraces 'smart pills' as some worry about intrusion
Last week, Novartis reportedly became the largest drug company to embrace "smart pills" by agreeing to pay California start-up firm Proteus Biomedical $24 million to acquire exclusive licenses and
